A prospective Study of Ultrasound Screening for Molar Pregnancies in Missed Miscarriages in Eastern Region of Afghanistan
DOI:
https://doi.org/10.53555/ans.v7i2.1521Keywords:
histopathology; miscarriage; mole; placenta; ultrasound.Abstract
Introduction Miscarriage is the natural death of an embryo or fetus before it is able to survive independently. The most common symptom of a miscarriage is vaginal bleeding. About 80% of miscarriage occur in the first 12 weeks of pregnancy.
Objective: The aim of this study was to prospectively evaluate the role of ultrasound examination in screening for molar changes in women diagnosed with a first-trimester miscarriage. In addition to examine the relationship between ultra- sound and histological features in the screening for molar changes in missed miscarriage.
Methods: A prospective cohort study was conducted on all missed miscarriages, with features suspicious of molar pregnancy, on transvaginal ultrasound and/or on histological examination in Nangarhar University Teaching Hospital over a 2-year period. All cases of molar pregnancy diagnosed histologically were examined and cross-referenced with cases diagnosed on ultrasound and with the supplementary report from the regional referral center. When available, maternal serum β-human chorionic gonadotropin (hCG) levels were recorded.
Results: seventy-one cases of suspected molar pregnancy were referred to the regional center for further histological opinion and follow-up, and nine cases were subsequently excluded from the final analysis because of the diagnosis of hydropic abortion (HA). In 45 cases a molar pregnancy was suspected at the initial scan. Of these, 35 (77.7%) were confirmed on histology, resulting in a 56% detection rate using ultrasound alone. In 20 cases hCG results were available, of which twelve were greater than two multiples of the median.
Conclusions: The diagnosis of both complete (CHM) and partial (PHM) hydatid form moles in first-trimester miscarriages is difficult. hCG is significantly higher in both CHM and PHM and, in conjunction with transvaginal ultrasound, could provide the screening test required to enable clinicians to counsel women more confidently towards non-surgical methods of management of their miscarriage, where histopathological examination is not available.
Downloads
References
2. Andersen N, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage. BMJ 2000; 350: 1708–1712.
3. Hassold JT. A cytogenetic study of repeated spontaneous abortion. Am J Hum Genet 1980; 32: 723–730.
4. Alberman ED. The abortus as a predictor of future trisomy 21. In Trisomy 21 (Down Syndrome), De la Cruz FF, Gerald PS(eds). University Park Press: Baltimore, MD,1981; 69–78.
5. Jeffers MD, O’Dwyer P, Curran B, Leader M, Gillan JE. Partial hydatidiform mole: a common but underdiagnosed condition. Int J Gynecol Obstet 1993; 12: 315–323.
6. Berkowitz RS. Natural history of partial molar pregnancy. Obstet Gynecol 1986; 66: 677–681.
7. Berkowitz RS, Goldstein DP. The diagnosis of molar pregnancy by ultrasound: a continuing challenge. Ultrasound Obstet Gynecol 1997; 9: 4–5.
8. Palmer JR. Advances in the epidemiology of gestational trophoblastic tumors. J Reprod Med 1994; 39: 155–162.
9. Fukunaga M. Early partial hydatidiform mole: prevalence, histopathology, DNA ploidy and persistence rate. Virchows Arch 2000; 437: 180–184.
10. Seckl MJ, Fisher RA, Salerno G, Rees H, Paradinas FJ, Foskett M, Newlands ES. Choriocarcinoma and partial hydatidiform moles. Lancet 2000; 356: 36–39.
11. Jauniaux E, Nicolaides KH. Early ultrasound diagnosis and follow-up of molar pregnancies. Ultrasound Obstet Gynecol 1998; 9: 17–21.
12. Jauniaux E. Ultrasound diagnosis and follow-up of gestational trophoblastic disease. Ultrasound Obstet Gynecol 1998; 11: 367–377.
13. Jauniaux E. Diagnosis and management of trophoblastic and non-trophoblastic tumours. In The Placenta: Basic Science and Clinical Practice, Kingdom J, Jauniaux E,O’Brien S (eds). Royal College of Obstetricians and Gynaecologists Press: London, UK, 2000; 221–237.
14. Jauniaux E, Kadri R, Hustin J. Partial mole and triploidy: screening patients with first trimester spontaneous abortion. Obstet Gynecol 1996; 88: 616–619.
15. Szulman AE, Surti U. The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations. Am J Obstet Gynecol 1978; 131: 665–671.
16. Szulman AE, Surti U. The syndromes of hydatidiform mole. II. Morphologic evolution of complete and partial mole. Am J Obstet Gynecol 1978; 132: 20–27.
17. Fox H. Differential diagnosis of hydatidiform mole. Gen Diagn Pathol 1997; 143: 117–125.
18. Jauniaux E. Partial moles: from postnatal to prenatal diagnosis. Placenta 1999; 20: 379–388.
19. Paradinas FJ. The histological diagnosis of hydatidiform moles. Curr Diagn Pathol 1994; 1: 24–31.
20. Sebire NJ, Rees H, Paradinas FJ, Seckl M, Newlands ES. The diagnostic implications of routine ultrasound examination in histologically confirmed early molar pregnancy. Ultrasound Obstet Gynecol 2001; 18: 662–665.
21. Heath V, Chadwick V, Cooke I, Manek S, MacKenzie IZ. Should tissue from pregnancy termination and uterine evacuation routinely be examined histologically? BJOG 2000; 107: 727–730.
22. Paradinas FJ. The diagnosis and prognosis of molar pregnancy: the experience of the National Referral Centre in London. Int J Gynecol Obstet 1998; 60: S57–S64.
23. Mosher R, Goldstein DP, Berkowitz R, Bernstein MR, Genest DR. Complete hydatidiform mole, comparison of clinicopathologic features, current and past. J Reprod Med 1998; 43: 21–27.
24. Jacobs PA, Szulman AE, Funkhouser J, Matsuura JS, Wilson CC. Human triploidy: relationship between parental origin of the additional haploid component and development of partial hydatidiform mole. Ann Hum Genet 1982; 46: 223–231.
25. Zaragoza MV, Surti U, Redline RW, Millie E, Chakravarti A, Hassold JT. Parental origin and phenotype of triploidy in spontaneous abortions: predominance of diandry and association with partial hydatidiform mole. Am J Hum Genet 2000; 66: 1807–1820.
26. Bouie J, Phillipe E, Giroud A, Boue A. Phenotypic expression of lethal anomalies in human abortuses. Teratology 1976; 14: 3–19.
27. Szulman AE, Surti U. The clinicopathologic profile of the partial hydatidiform mole. Obstet Gynecol 1982; 59: 597–602. 28. Lazarus E, Hulka CA, Siewert B, Levine D. Sonographic appearance of early complete molar pregnancies. J Ultrasound Med 1999; 18: 589–593.
29. Benson CB, Genest DR, Bernstein MR, Soto-Wright V, Goldstein DP, Berkowitz RS. Sonographic appearance of first trimester complete hydatidiform moles. Ultrasound Obstet Gynecol 2000; 16: 188–191.
30. Jauniaux E, Campbell S. Ultrasonographic assessment of placental abnormalities. Am J Obstet Gynecol 1990; 163: 1650–1658.
31. Naumoff P, Szulman AE, Weinstein B, Mazer J, Surti U. Ultrasonography of partial hydatidiform mole. Radiology 1981; 140: 467–470.
32. Fine C, Bundy AL, Berkowitz R, Boswell SB, Berezin AF, Doubilet PM. Sonographic diagnosis of partial hydatidiform mole. Obstet Gynecol 1989; 73: 414–418.
33. Lindholm H, Flam F. The diagnosis of molar pregnancy by sonography and gross morphology. Acta Obstet Gynecol Scand 1999; 78: 6–9.
34. Jauniaux E, Bersinger NA,Gulbis B,Meuris S. The contribution of maternal serum markers in the early prenatal diagnosis of molar pregnancies. Hum Reprod 1999; 14: 842–850
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 International Journal For Research In Applied And Natural Science (ISSN: 2208-2085)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
In consideration of the journal, Green Publication taking action in reviewing and editing our manuscript, the authors undersigned hereby transfer, assign, or otherwise convey all copyright ownership to the Editorial Office of the Green Publication in the event that such work is published in the journal. Such conveyance covers any product that may derive from the published journal, whether print or electronic. Green Publication shall have the right to register copyright to the Article in its name as claimant, whether separately
or as part of the journal issue or other medium in which the Article is included.
By signing this Agreement, the author(s), and in the case of a Work Made For Hire, the employer, jointly and severally represent and warrant that the Article is original with the author(s) and does not infringe any copyright or violate any other right of any third parties, and that the Article has not been published elsewhere, and is not being considered for publication elsewhere in any form, except as provided herein. Each author’s signature should appear below. The signing author(s) (and, in